PARIS, Oct 18 (Reuters) - Vaccine company Valneva
reported on Monday positive Phase 3 results for its inactivated,
adjuvanted COVID-19 vaccine candidate VLA2001, for which it is
hoping to get a licence.
Valneva added it was preparing for trials in children aged
between 5-12 years and for a Valneva sponsored booster trial to
evaluate VLA2001s booster performance for people in need of a
COVID vaccine booster shot.
(Reporting by Sudip Kar-Gupta; Editing by Kim Coghill)